Cardioprotective Effects of Taurisolo® in Cardiomyoblast H9c2 Cells under High-Glucose and Trimethylamine N-Oxide Treatment via De Novo Sphingolipid Synthesis

<div>Representative microphotographs of HG-H9c2 cells. Cardiomyocyte was identified with α-actin antibody (green signal), and the nucleus was identified by DAPI (blue signal). (a) H9c2 cell growth with 44 mM glucose (HG-H9c2). (b) HG-H9c2 was treated for 72 h with Tau (0.5 μg/μL). (c) HG-H9c2 cell was treated for 72 h with TMAO (50 μM). (d) HG-H9c2 cell was treated for 72 h with TMAO/Tau combination.</div>

Oxidative Medicine and Cellular Longevity

fig5

Figure 5

Figure 5: Cardioprotective Effects of Taurisolo® in Cardiomyoblast H9c2 Cells under High-Glucose and Trimethylamine N-Oxide Treatment via De Novo Sphingolipid Synthesis

Figure 5 | Cardioprotective Effects of Taurisolo® in Cardiomyoblast H9c2 Cells under High-Glucose and Trimethylamine N-Oxide Treatment via De Novo Sphingolipid Synthesis 